Companies / Latvia
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Latvia's Reimbursement Spending Booms
March 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Spending on reimbursed medicines by Latvia's state health insurance agency last year increased by 44% to LVL30.2mn (US$52.6mn), with per capita spending increasing by 18% to LVL86 (US$150).